A retrospective study of consequences of shifting from rasagiline to high-dose safinamide in parkinson's disease patients
Latest Information Update: 22 Feb 2022
At a glance
- Drugs Safinamide (Primary) ; Rasagiline
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 22 Feb 2022 New trial record